Skip to main
MASI

Masimo (MASI) Stock Forecast & Price Target

Masimo (MASI) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Masimo Corp's healthcare segment, a significant revenue driver, is experiencing growth due to increased demand for its core SET pulse oximetry business and advancements in monitoring technologies such as capnography and hemodynamics. The company anticipates recognizing $507 million in unrecognized contract revenue over the next year, reflecting a year-over-year increase of 17%, while projecting EBIT margins to expand steadily through 2028. Furthermore, Masimo's international market penetration and the promising growth expectations in advanced monitoring platforms are indicative of strong future revenue growth, supported by new product launches.

Bears say

Masimo Corp faces a negative outlook primarily due to the anticipated impact of tariffs, with forecasts suggesting a $16 million to $17 million hit in FY25 that could reduce operating margins by approximately 110 basis points. Additionally, there are numerous risks affecting the company's financial stability, including potential delays in new product rollouts, challenges in supply chain management, and increased competition within both its healthcare and non-healthcare segments. Furthermore, the recent downward revision of the revenue forecast for Q4 2025, coupled with pricing pressure and declining hospital demand for capital equipment, further complicates the company’s growth prospects and revenue generation capabilities.

Masimo (MASI) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Masimo (MASI) Forecast

Analysts have given Masimo (MASI) a Buy based on their latest research and market trends.

According to 5 analysts, Masimo (MASI) has a Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $188.80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $188.80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Masimo (MASI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.